Benefits Beat Risks in Combo Therapy for Crohn's Disease Doctors Lounge ... for the risks of combination therapy with infliximab and azathioprine to outweigh the benefits, when compared with infliximab monotherapy, according to research published in the January issue of Clinical Gastroenterology and Hepatology. ... |
